N-3 fatty acids for improvement of Respiratory Outcomes – The N3RO trial Scientific title: Docosahexaenoic acid (DHA) for the reduction of bronchopulmonary dysplasia in preterm infants born at less than 29 weeks gestat - Dysplasia - Document - PDFSEARCH.IO

First Page	Meta Content
	N-3 fatty acids for improvement of Respiratory Outcomes – The N3RO trial Scientific title: Docosahexaenoic acid (DHA) for the reduction of bronchopulmonary dysplasia in preterm infants born at less than 29 weeks gestat Add to Reading List Document Date: 2015-01-07 22:40:59 Open Document File Size: 402,89 KB Share Result on Facebook City Adelaide / / Country Australia / / Facility Children’s Health Research Institute / / IndustryTerm fish oil / fish oil capsules / study solution / oil / control solution / / MedicalCondition bronchopulmonary dysplasia / bruise / pain / lung disease / inflammation / pregnancy complications / preterm birth / / Organization Australian Government / Children’s Health Research Institute / / Person Michael Stark / Brenda Penny / Andrew McPhee / Carmel Collins / / / Position executive / / Technology antibodies / / SocialTag Food and drink Docosahexaenoic acid Bronchopulmonary dysplasia Omega-3 fatty acid Breastfeeding Preterm birth Pregnancy Fish oil Human breast milk Fatty acids

N-3 fatty acids for improvement of Respiratory Outcomes – The N3RO trial Scientific title: Docosahexaenoic acid (DHA) for the reduction of bronchopulmonary dysplasia in preterm infants born at less than 29 weeks gestatAdd to Reading List